Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer… - Blood, The Journal …, 2002 - ashpublications.org
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
[引用][C] Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD KOTTARIDIS, RE GALE, SE LANGABEER… - Blood, 2002 - pascal-francis.inist.fr
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute
myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal …
myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal …
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - Blood, 2002 - discovery.ucl.ac.uk
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - Blood, 2002 - europepmc.org
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - Blood, 2002 - cir.nii.ac.jp
抄録< jats: p> FLT3 mutations, either internal tandem duplications (ITDs) or aspartate
residue 835 (D835) point mutations, are present in approximately one third of patients with …
residue 835 (D835) point mutations, are present in approximately one third of patients with …
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - …, 2002 - pubmed.ncbi.nlm.nih.gov
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
[PDF][PDF] Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - BLOOD, 2002 - core.ac.uk
Approximately 80% of patients with acute myeloid leukemia (AML) younger than 55 years of
age achieve complete remission (CR) following intensive induction therapy. 1 However, the …
age achieve complete remission (CR) following intensive induction therapy. 1 However, the …
[HTML][HTML] Studies of FLT3mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - Blood, 2002 - Elsevier
FLT3mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
[PDF][PDF] Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - researchgate.net
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
[PDF][PDF] Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer, ME Frew… - BLOOD, 2002 - Citeseer
Approximately 80% of patients with acute myeloid leukemia (AML) younger than 55 years of
age achieve complete remission (CR) following intensive induction therapy. 1 However, the …
age achieve complete remission (CR) following intensive induction therapy. 1 However, the …